newsfilter
← Latest News
GlobeNewswire·

Interpace Biosciences Announces First Quarter 2025 Financial and Business Results

●Q1 Revenue of $11.5 million; a 13% increase year-over-year ●Q1 Cash Collections of $11.3 million; a 10% increase year-over-year to record levels ●Q1 Thyroid test volume up 16% year-over-year to record levels ●Q1